Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, using an AI-powered discovery platform. Its lead product, GLP-1 Edge™, is a food-grade peptide that enhances the body’s GLP-1 response to support appetite regulation and metabolic health. Designed for seamless integration into formats like bars, shakes, and supplements, it enables natural weight management without pharmaceutical intervention. The company’s proprietary AI platform accelerates the design of targeted peptides, leveraging patent-pending academic technology to expand into additional health applications. Lembas combines computational biology with food science to bring precision bioactives into everyday nutrition.